All participants who give consent for participation and who fulfil the inclusion criteria will be randomised. Randomisation will be performed centrally by the study manager using an online bespoke randomisation module provided and managed by Norwich Clinical Trials Unit (NCTU). The allocation sequence will be generated by the NCTU applying a permuted block design with random blocks stratified by study centre. The randomisation list remains with NCTU for the whole duration of the study. Thus, randomisation will be conducted without any influence of the principal investigators, MHSWs, or REPs.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.